These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2328508)

  • 1. Evidence for the role of spinal cord systems in Parkinson's disease-associated pain.
    Sage JI; Kortis HI; Sommer W
    Clin Neuropharmacol; 1990 Apr; 13(2):171-4. PubMed ID: 2328508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex dystonia of Parkinson's disease: clinical features and relation to plasma levodopa profile.
    McHale DM; Sage JI; Sonsalla PK; Vitagliano D
    Clin Neuropharmacol; 1990 Apr; 13(2):164-70. PubMed ID: 2328507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity.
    Krack P; Pollak P; Limousin P; Benazzouz A; Deuschl G; Benabid AL
    Brain; 1999 Jun; 122 ( Pt 6)():1133-46. PubMed ID: 10356065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forms of dystonia in patients with Parkinson's disease.
    Kidron D; Melamed E
    Neurology; 1987 Jun; 37(6):1009-11. PubMed ID: 3587617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical characteristics of painful dystonic foot response in patients with Parkinson's disease].
    Hara H; Wakayama Y; Kawase J
    Rinsho Shinkeigaku; 1989 Sep; 29(9):1101-5. PubMed ID: 2598534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Off" painful dystonia in Parkinson's disease treated with botulinum toxin.
    Pacchetti C; Albani G; Martignoni E; Godi L; Alfonsi E; Nappi G
    Mov Disord; 1995 May; 10(3):333-6. PubMed ID: 7651452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dystonia in Parkinson's disease: clinical and pharmacological features.
    Poewe WH; Lees AJ; Stern GM
    Ann Neurol; 1988 Jan; 23(1):73-8. PubMed ID: 3345068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. End-of-dose dystonia in Parkinson's disease.
    Bravi D; Mouradian MM; Roberts JW; Davis TL; Chase TN
    Neurology; 1993 Oct; 43(10):2130-1. PubMed ID: 8413978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous levodopa infusions to treat complex dystonia in Parkinson's disease.
    Sage JI; McHale DM; Sonsalla P; Vitagliano D; Heikkila RE
    Neurology; 1989 Jul; 39(7):888-91. PubMed ID: 2472582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early morning dystonia in Parkinson's disease.
    Currie LJ; Harrison MB; Trugman JM; Bennett JP; Wooten GF
    Neurology; 1998 Jul; 51(1):283-5. PubMed ID: 9674823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facilitated temporal summation of pain at spinal level in Parkinson's disease.
    Perrotta A; Sandrini G; Serrao M; Buscone S; Tassorelli C; Tinazzi M; Zangaglia R; Pacchetti C; Bartolo M; Pierelli F; Martignoni E
    Mov Disord; 2011 Feb; 26(3):442-8. PubMed ID: 21462260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Secondary effects of prolonged levodopa therapy in Parkinson's disease].
    Peiró Grasa A; Grau-Veciana JM
    Med Clin (Barc); 1985 Jun; 85(3):88-91. PubMed ID: 4021630
    [No Abstract]   [Full Text] [Related]  

  • 13. Dystonia in untreated parkinsonism.
    LeWitt PA; Burns RS; Newman RP
    Clin Neuropharmacol; 1986; 9(3):293-7. PubMed ID: 3719574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early-morning dystonia. A late side effect of long-term levodopa therapy in Parkinson's disease.
    Melamed E
    Arch Neurol; 1979 May; 36(5):308-10. PubMed ID: 444100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic strategies to prevent motor complications in Parkinson's disease.
    Kieburtz K
    J Neurol; 2008 Aug; 255 Suppl 4():42-5. PubMed ID: 18821085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meige's syndrome during long-term dopaminergic therapy in Parkinson's disease.
    Weiner WJ; Nausieda PA
    Arch Neurol; 1982 Jul; 39(7):451-2. PubMed ID: 7103786
    [No Abstract]   [Full Text] [Related]  

  • 17. Morphine in tardive and idiopathic dystonia (short communication).
    Berg D; Becker G; Naumann M; Reiners K
    J Neural Transm (Vienna); 2001; 108(8-9):1035-41. PubMed ID: 11716139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sudden appearance of invalidating dyskinesia-dystonia and off fluctuations after the introduction of levodopa in two dopaminomimetic drug naive patients with stage IV Parkinson's disease.
    Onofrj M; Paci C; Thomas A
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):605-6. PubMed ID: 9771801
    [No Abstract]   [Full Text] [Related]  

  • 19. Dystonia and Parkinson's disease.
    Carella F; Giovannini P; Girotti F; Testa D; Caraceni T
    Adv Neurol; 1993; 60():558-61. PubMed ID: 8420191
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of levodopa-responsive camptocormia associated with advanced Parkinson's disease.
    Ho B; Prakash R; Morgan JC; Sethi KD
    Nat Clin Pract Neurol; 2007 Sep; 3(9):526-30. PubMed ID: 17805247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.